ELI LILLY & Co — Director's Dealing 2022

Nov 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-11-07

Reporting Person: LILLY ENDOWMENT INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-07	Common Stock	S	14280	$362.296	Disposed	103208115	Direct
2022-11-07	Common Stock	S	17916	$363.539	Disposed	103190199	Direct
2022-11-07	Common Stock	S	19415	$364.472	Disposed	103170784	Direct
2022-11-07	Common Stock	S	9187	$365.391	Disposed	103161597	Direct
2022-11-07	Common Stock	S	2787	$366.423	Disposed	103158810	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.00 to $363.99, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.01 to $365.00, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.01 to $365.99, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.04 to $366.90, inclusive.